For the first time, we observed that bergenin exerts its powerful antioxidant effect and inhibits TGF-β1-induced myofibroblast transformation through a p62–Nrf2 positive feedback loop, thereby alleviating bleomycin-induced pulmonary fibrosis. The gene discussed is NFE2L2; the disease is pulmonary fibrosis.